Mississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

Anemia is highly prevalent in patients with chronic heart failure (HF) and is associated with poor clinical outcomes. Multiple mechanisms contribute to anemia in chronic HF, and subnormal ...

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people ...

Diamond-Blackfan anemia (DBA) is a rare, life-threatening genetic blood disorder ... leaving the majority of DBA patients ...

Anemia, a condition characterized by a reduction in red blood cells or hemoglobin, limits oxygen transport within the body.

Sickle cell anemia requires ongoing, lifelong treatment to improve quality of life and prevent complications. Treatment of sickle cell anemia includes taking measures to treat anemia, prevent ...

Saeed Sadeghi, MD, explores the future treatment landscape for anemia in lower-risk myelodysplastic syndromes (LR-MDS), ...

If you are exposed to certain medications like sulfa antibiotics, your red blood cells may hemolyze, causing anemia. If you have G6PD deficiency, it is important for you to know what medications/foods ...

Before this successful procedure, only seven known transplants for Pearson Syndrome had been conducted worldwide. The young ...

Desidustat is a small molecule inhibitor of hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) discovered and developed by Zydus Lifesciences for the treatment of anemia associated with chronic ...